(Q41209462)

28 September 2017

1 reference

reason for preferred rank

title

3 Adriamycin and Related Anthracycline Antibiotics (English)

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

Adriamycin and related anthracycline antibiotics (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A400611

21 April 2023

0 references

1 reference

J. R. Brown

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A400611

21 April 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=400611

21 April 2023

publication date

1 January 1978

1 reference

Progress in medicinal chemistry

28 September 2017

1 reference

28 September 2017

15

1 reference

28 September 2017

125-164

1 reference

Adriamycin (14-hydroxydaunomycin), a novel antitumor antibiotic

28 September 2017

6

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Physical and chemical characteristics and structure of carminomycin, a new antitumor antibiotic

21 April 2023

7

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Antitumor agents. XIII. Isolation and absolute configuration of carminomycin I from Streptosporangium species

21 April 2023

8

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Adriamycin. A new anticancer drug with significant clinical activity

21 April 2023

9

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

Adriamycin—A Review

11

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

[On the identification of a series of anthracycline pigments from Streptomyces galilaeus Stamm JA 3043 (galirubine and galirubinone)]

21 April 2023

16

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

[Alpha-2-rhodomycins, alpha-citromycins, gamma-citromycins]

21 April 2023

17

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

The Structure of Isoquinocycline A. An X-Ray Crystallographic Determination

21 April 2023

18

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

ε1-Pyrromycinone, a new anthracyclinone from Streptomyces galilaeus JA 3043

21 April 2023

20

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

Structure of nogalamycin

21

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

The identification of ciclacidine an antibiotic from Streptomyces capoamus sp. nov.

21 April 2023

22

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

N1-Pyrromycinone, a new tetracenequinone (anthracyclinone) from streptomyces sp. I-8

21 April 2023

23

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Steffimycin B, a DNA binding agent

21 April 2023

24

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Rhodomycine, VI; Antibiotica aus Actinomyceten, XLVII. ε-Rhodomycinon

21 April 2023

25

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Rhodomycine, X. Antibiotica aus Actinomyceten, LIII. α-Rhodomycinon, β1-Rhodomycinon, 10-Desoxy-γ-rhodomycinon

21 April 2023

27

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

The absolute configuration of anthracyclinones

21 April 2023

28

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

[Configuration and structure of alpha-rhodomycinone, beta-rhodomycinone and beta-iso-rhodomycinone]

21 April 2023

29

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

The total absolute configuration of daunomycin

21 April 2023

30

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Letter: A 13C nuclear magnetic resonance study of the biosynthesis of daunomycin from 13CH313CO2Na

21 April 2023

34

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Structure of Daunomycin; X-ray Analysis of N-Br-Acetyl-Daunomycin Solvate

21 April 2023

37

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

New antitumor antibiotics, aclacinomycins A and B

21 April 2023

39

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Antimicrobial Agents and Chemotherapy

21 April 2023

40

68

Keller-Schierlein

1970

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Metabolic products of microorganisms. Structure of cinerubine B

21 April 2023

41

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Constituution and configuration of beta-rhodomycin II and beta-iso-rhodomycin II

21 April 2023

43

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Antibiotics produced by Streptomyces. VII. Cytotetrin, a new antitumor antibiotic

21 April 2023

48

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Violamycin, a new red-pigment antibiotic

21 April 2023

51

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Mitocromin: an antibiotic with antitumor activity

21 April 2023

52

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Requinomycin, an inhibitor of R-factor transfer: isolation, characterization and properties.

21 April 2023

53

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Synthetic studies on eta-pyrromycinone. V. Total synthesis of eta-pyrromycinone

21 April 2023

54

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Letter: Regiospecif total synthesis of (plus or minus)-9-deoxy daunomycinone

21 April 2023

59

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Daunomycinone analogues via the Diels-Alder reaction. Synthesis and chemistry of some 6,11-dihydroxy-5,12-naphthacenediones

21 April 2023

60

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Journal of the Chemical Society. Chemical communications

21 April 2023

68

973

Marsh

1967

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

A preparative synthesis of 3-amino-2,3,6-trideoxy-l-lyxo-hexose (daunosamine) hydrochloride from d-mannose

21 April 2023

69

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Reaction of derivatives of methyl 2,3-O-benzylidene-6-deoxy-alpha-L-mannopyranoside with butyllithium: synthesis of methyl 2,6-dideoxy-4-O-methyl-alpha-L-erythro-hexopyranosid-3-ulose

21 April 2023

70

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Total synthesis of the antitumor antibiotic daunorubicin. Coupling of the sugar and aglycone

21 April 2023

72

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Induction of DNA degradation in vivo by adriamycin

21 April 2023

74

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

75

21

137

Newsome

1977

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Genetic toxicology of mitomycin C, actinomycins, daunomycin and adriamycin

21 April 2023

77

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Inhibition of coenzyme Q10-enzymes, succinoxidase and NADH-oxidase, by adriamycin and other quinones having antitumor activity

21 April 2023

79

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Effects of adriamycin on surface properties of sarcoma 180 ascites cells

21 April 2023

80

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Affinity of adriamycin to phospholipids a possible explanation for cardiac mitochondrial lesions

21 April 2023

81

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells

21 April 2023

82

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

84

32

1137

Meriwether

1972

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Cellular pharmacodynamics of several anthracycline antibiotics

21 April 2023

85

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Transport and binding of daunorubicin, adriamycin, and rubidazone in ehrlich ascites tumour cells

21 April 2023

86

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

ON PHYSICO-CHEMICAL INTERACTIONS BETWEEN DAUNOMYCIN AND NUCLEIC ACIDS

21 April 2023

88

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Interaction of daunomycin and its derivatives with DNA

21 April 2023

89

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Spectrophotometric study of the DNA-daunorubicin complex

21 April 2023

90

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Spectrophotometric and fluorescence polarization studies of the binding of ethidium, daunomycin and mepacrine to DNA and to poly(I-C)

21 April 2023

92

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Physicochemical properties of complexes between deoxyribonucleic acid and antibiotics which affect ribonucleic acid synthesis (actinomycin, daunomycin, cinerubin, nogalamycin, chormomycin, mithramycin, and olivomycin)

21 April 2023

94

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Variation of the supercoils in closed circular DNA by binding of antibiotics and drugs: Evidence for molecular models involving intercalation

21 April 2023

95

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

On the binding of actinomycin and of daunomycin to DNA: A calorimetric and spectroscopic investigation

21 April 2023

96

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Studies on the mode of interaction of daunomycin with DNA

21 April 2023

97

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Differential interaction of nogalamycin with DNA of varying base composition

21 April 2023

98

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Base Specificity in the Interaction of Polynucleotides with Antibiotic Drugs

21 April 2023

99

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Differential reactivity of intercalative dyes with bacteriophage TP-84 DNA

21 April 2023

100

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Studies on the interactions of nogalamycin with duplex DNA

21 April 2023

101

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Interaction of nogalamycin with DNA

21 April 2023

102

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Interaction of nogalamycin with deoxyribonucleic acid

21 April 2023

103

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Research into fish diseases

21 April 2023

104

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Binding of daunomycin to nonhistone proteins from rat liver

21 April 2023

106

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

The inhibition of RNA polymerase by daunomycin

21 April 2023

107

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

108

36

2891

Momparler

1976

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

The inhibition in vitro of DNA polymerase and RNA polymerases by daunomycin and adriamycin

21 April 2023

109

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Interaction of some daunomycin derivatives with deoxyribonucleic acid and their biological activity

21 April 2023

110

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

111

32

323

Kim

1972

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

114

32

511

Wang

1972

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Inhibitors of an RNA-dependent DNA polymerase

21 April 2023

116

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

117

36

3016

Tomita

1976

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Effect of daunomycin on HeLa cell nucleic acid synthesis.

21 April 2023

118

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Daunorubicin inhibition of DNA-dependent RNA polymerases from Ehrlich ascites tumor cells

21 April 2023

119

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

Molecular Pharmacology

121

11

640

Barthelemy-Qavey

1975

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

123

30

966

Silvestrini

1970

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

124

35

1542

Mizuno

1975

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

Molecular Pharmacology

125

8

551

Ekann

1972

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

128

33

2954

Silvestrini

1973

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

The pharmacokinetics of daunomycin in man

21 April 2023

130

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Journal of Pharmacology and Experimental Therapeutics

21 April 2023

132

91

337

Bachur

1974

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Journal of Pharmacology and Experimental Therapeutics

21 April 2023

134

195

41

Takanashi

1975

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Drug Metabolism and Disposition

21 April 2023

135

4

79

Takanashi

1976

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Microbial reduction of the side-chain carbonyl of daunorubicin and N-acetyldaunorubicin

21 April 2023

138

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Microbial conversion of anthracycline antibiotics

21 April 2023

139

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

The pharmacokinetics of daunomycin in man

21 April 2023

142

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

143

32

1177

Yesair

1972

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Pharmacokinetics and metabolism of adriamycin in man

21 April 2023

145

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Daunorubicin metabolism in acute nonlymphocytic leukemia

21 April 2023

146

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule.

21 April 2023

148

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Pharmacokinetics and metabolism of adriamycin in man

21 April 2023

150

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

The persistence of adriamycin in man and rat.

21 April 2023

151

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

152

36

216

Creasey

1976

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Plasma adriamycin and daunorubicin levels by fluorescence and radioimmunoassay

21 April 2023

153

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

154

37

1416

Benjamin

1977

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

The effects of adriamycin and daunomycin on antitumoral immune effector mechanisms in an allogeneic system

21 April 2023

155

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Effects of adriamycin and daunomycin on spleen cell populations in normal and tumor allografted mice

21 April 2023

156

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

158

33

1837

Schwartz

1973

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

159

37

1719

Orsini

1977

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

160

37

815

Mantovani

1977

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

161

30

2572

Bonadonna

1970

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Therapeutic effect and toxicity of adriamycin in patients with neoplastic disease

21 April 2023

162

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Clinical trials with adriamycin

21 April 2023

163

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Adriamycin and fibrinolysis

21 April 2023

165

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Skin ulcers due to adriamycin

21 April 2023

168

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

A clinicopathologic analysis of adriamycin cardiotoxicity

21 April 2023

170

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

The cardiotoxicity of adriamycin and daunomycin in children

21 April 2023

171

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Adriamycin cardiomyopathy--risk factors

21 April 2023

174

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Function of myocardial mitochondria in the adriamycin-induced cardiomyopathy of rabbits

21 April 2023

178

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Alterations in DNA synthesis in cardiac tissue induced by adriamycin in vivo—Relationship to fatal toxicity

21 April 2023

179

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

180

36

1580

Merski

1976

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Inhibition of RNA synthesis in mitochondria by daunomycin

21 April 2023

181

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Antimitochondrial activity of adriamycin and daunomycin on saccharomyces cerevisiae

21 April 2023

182

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Bioenergetics in clinical medicine: prevention by forms of coenzyme Q of the inhibition by adriamycin of coenzyme Q10-enzymes in mitochondria of the myocardium

21 April 2023

183

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Adriamycin: Energy metabolism and mitochondrial oxidations in the heart of treated rabbits

21 April 2023

184

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Journal of Pharmacology and Experimental Therapeutics

21 April 2023

185

178

216

Mhatre

1971

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Inhibition of oxidative phosphorylation in tumor cells and mitochondria by daunomycin and adriamycin

21 April 2023

186

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Adriamycin associated cardiotoxicity: research on prevention with coenzyme Q

21 April 2023

187

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

188

36

1462

Fioretti

1976

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Cardiomyopathy after widely separated courses of adriamycin exacerbated by actinomycin-D and mithramycin

21 April 2023

189

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Adriamycin cardiotoxicity in children.Case reports, literature review, and risk factors

21 April 2023

190

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Adriamycin cardiomyopathy: enhanced cardiac damage in rabbits with combined drug and cardiac irradiation

21 April 2023

191

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Adriamycin and Radiation: Synergistic Cardiotoxicity

21 April 2023

192

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Inhibition of adriamycin cardiotoxicity by acetyldaunomycin

21 April 2023

195

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Prevention of the Cardiotoxic Effects of Adriamycin and Daunomycin in the Isolated Dog Heart

21 April 2023

196

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Digoxin does not prevent daunorubicin or adriamycin from binding to rat heart muscle

21 April 2023

197

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

The effect of digoxin on the binding of adriamycin to cat heart muscle

21 April 2023

198

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Rule governing Cell Division in Anabaena

21 April 2023

202

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

204

36

496

Marks

1976

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Concanavalin A as a carrier of daunomycin

21 April 2023

205

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

206

35

1175

Hurvitz

1975

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

207

35

1182

Levy

1975

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Cancer Biochemistry Biophysics

21 April 2023

208

1

197

Hurvitz

1976

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Melanotropin–daunomycin conjugate shows receptor-mediated cytotoxicity in cultured murine melanoma cells

21 April 2023

209

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

Targeting of drugs

210

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Effects of the stereochemical configuration on the interaction of some daunomycin derivatives with DNA.

21 April 2023

212

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

The interaction of adriamycin and its beta anomer with DNA

21 April 2023

213

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Interaction of some daunomycin derivatives with deoxyribonucleic acid and their biological activity

21 April 2023

214

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Antitumor activity of some derivatives of daunorubicin at the amino and methyl ketone functions

21 April 2023

216

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Structure-activity relation of daunorubicin and its peptide derivatives

21 April 2023

219

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Interaction specificity of the anthracyclines with deoxyribonucleic acid

21 April 2023

220

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

221

36

DiMarco

1976

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone

21 April 2023

222

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Synthesis and antitumor activity of 4'-deoxydaunorubicin and 4'-deoxyadriamycin

21 April 2023

223

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Stereocontrolled glycosidation of daunomycinone. Synthesis and biological evaluation of 6-hydroxy-L-arabino analogues of antitumor anthracyclines

21 April 2023

224

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Adriamycin analogs. Periodate oxidation of adriamycin

21 April 2023

228

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Antitumor activity of some derivatives of daunorubicin at the amino and methyl ketone functions

21 April 2023

230

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Clinical study of rubidazone (22 050 R.P.), a new daunorubicin-derived compound, in 170 patients with acute leukemias and other malignancies

21 April 2023

234

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Rubidazone vs adriamycin: an evaluation of their differential toxicity in the spleen colony assay system

21 April 2023

235

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Synthesis and biological evaluation of some 14-O-acyl derivatives of adriamycin.

21 April 2023

236

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

238

36

143

Krishan

1976

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

239

36

2114

Krishan

1976

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

New anthracycline antibiotics, rhodirubins

21 April 2023

240

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

The structure of baumycins A1, A2, B1, B2, C1 and C2

21 April 2023

241

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

New antitumor antibiotics: musettamycin and marcellomycin from bohemic acid complex

21 April 2023

242

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Production of nineteen anthracyclic compounds by Streptomyces galilaeus MA144-M1

21 April 2023

243

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

The structure of aklavin

244

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Nucleic acid binding drugs. Part IV. The crystal structure of the anti-cancer agent daunomycin

21 April 2023

245

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Synthetic approaches to adriamycin involving Diels-Alder reactions of photochemically generated bisketenes. Total synthesis of islandicin and digitopurpone

21 April 2023

248

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Regiochemical control in the Diels-Alder reactions of substituted naphthoquinones. Model studies on a regiospecific approach to adriamycinone

21 April 2023

251

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Bilary disposition of adriamycin

21 April 2023

260

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

Cancer Treatment Reports

261

61

893

DiMarco

1977

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Cellular effects of combined adriamycin and x-irradiation in human tumor cells

21 April 2023

262

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Strand scission of DNA by bound adriamycin and daunorubicin in the presence of reducing agents

21 April 2023

263

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

Molecular Pharmacology

264

13

901

Bachur

1977

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response

21 April 2023

265

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Inhibition by adriamycin of the mitochondrial biosynthesis of coenzyme Q10 and implication for the cardiotoxicity of adriamycin in cancer patients

21 April 2023

266

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Inhibition of the cardiac mitochondrial calcium pump by adriamycin in vitro

21 April 2023

268

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Higher Antitumor Efficacy of Daunomycin When Linked to Dextran: In Vivo and In Vitro Studies 2

21 April 2023

270

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

271

38

467

Daskal

1978

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

272

38

365

Israel

1978

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

Cancer Treatment Reports

273

62

111

Vecehi

1978

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Stereochemical requirements in the antitumor anthracyclines

21 April 2023

274

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

276

37

4523

Supino

1977

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

Adriamycin analogs. 2. Synthesis of 13-deoxyanthracyclines

21 April 2023

277

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70255-8

21 April 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=400611

21 April 2023

1 reference